Executive Vice President, Strategic Alliances & Global Head of Digital Medicine
Widely recognized as a preeminent thought leader in digital therapeutics, Ed joins EVERSANA from Dthera Sciences, where as its CEO, he earned the FDA’s Breakthrough Device designation for a digital therapeutic to treat the behavioral symptoms of Alzheimer’s disease. His pioneering work in this field has led him to serve in highly visible roles at numerous digital therapeutic and digital medicine events throughout the world, including DTx-Science (Bordeaux, France), LSX World Congress (London, UK), CNS Summit (Boca Raton, FL), DTx West (San Mateo, CA), and Evercore Healthcare Conference (Boston, MA). Ed championed digital medicines as chair of the first digital therapeutics conferences in the industry – DTxDM (San Jose, CA) and DTx East (Boston, MA), as well as the inaugural DTx Europe (London, UK).
With a background in executive leadership across numerous industries including digital health, pharma and biotech, technology, investment banking, and public markets, he is uniquely positioned to lead digital medicine and strategic alliance initiatives in this rapidly expanding sector. He excels at finding creative and asymmetric pathways to drive success and is adept at corporate development and these skills have enabled him to build high profile strategic partnerships. Ed holds a Master’s of Science in Management from Warrington College of Business Administration at the University of Florida and a bachelor’s degree in telecommunications the University of Florida.